Filing Details
- Accession Number:
- 0001610717-23-000214
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-21 17:31:21
- Reporting Period:
- 2023-07-19
- Accepted Time:
- 2023-07-21 17:31:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1770787 | 10X Genomics Inc. | TXG | Laboratory Analytical Instruments (3826) | 455614458 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1786391 | J. Benjamin Hindson | 10X Genomics, Inc. 6230 Stoneridge Mall Road Pleasanton CA 94588 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2023-07-19 | 12,972 | $5.04 | 297,208 | No | 4 | M | Direct | |
| Class A Common Stock | Acquisiton | 2023-07-19 | 968 | $11.48 | 298,176 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2023-07-19 | 13,940 | $60.03 | 284,236 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2023-07-19 | 12,972 | $0.00 | 12,972 | $5.04 |
| Class A Common Stock | Stock Option (right to buy) | Disposition | 2023-07-19 | 968 | $0.00 | 968 | $11.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2028-11-02 | No | 4 | M | Direct | |
| 30,282 | 2029-05-10 | No | 4 | M | Direct |
Footnotes
- The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2023.
- This transaction was executed in multiple trades at prices ranging from $60.00 to $60.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- All of the shares subject to the option are fully vested and exercisable as of the date hereof.
Billionaire Hedge Funds
